Search Results - Mark Sumeray

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine by Isabel Leroux-Roels, Jacques Bruhwyler, Lilli Stergiou, Mark Sumeray, Jasper Joye, Cathy Maes, Paul-Henri Lambert, Geert Leroux-Roels

    Published in Vaccines (2023-02-01)
    Get full text
    Article


  2. 2

    Phase 1 clinical trial of eneboparatide, a novel PTH receptor 1 agonist by Michel Ovize, Soraya Allas, Michael D Culler, Stephane Milano, Taha Ouldrouis, Mark Sumeray, Jeroen van de Wetering de Rooij, Michael Mannstadt

    Published in Endocrine Connections (2025-06-01)
    Get full text
    Article


Search Tools: